OBJECTIVES: The purpose of this study was to better understand substance use behaviors and deleterious health consequences among individuals with HIV. METHODS: We examined a multicenter cohort of HIV-infected patients (n = 3,413) receiving care in 4 US cities (Seattle, Birmingham, San Diego, Boston) between December 2005 and April 2010 in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS). We used generalized estimating equations to model specific substance use outcomes. RESULTS: Overall, 24% of patients reported recent use of marijuana; 9% reported amphetamine use, 9% reported crack-cocaine use, 2% reported opiate use, 3.8% reported injection drug use, and 10.3% reported polydrug use. In adjusted multivariable models, those who reported unprotected anal sex had higher odds of marijuana, amphetamine, injection drug, and polydrug use. An increased number of distinct vaginal sexual partners was associated with polydrug and crack-cocaine use. Nonadherence to antiretroviral therapy was associated with the use of all substances other than marijuana. CONCLUSIONS: The co-occurrence of substance use, unprotected intercourse, and medication nonadherence could attenuate the public health benefits of test, treat, and link to care strategies. Prevention programs are needed that address these coprevalent conditions.
OBJECTIVES: The purpose of this study was to better understand substance use behaviors and deleterious health consequences among individuals with HIV. METHODS: We examined a multicenter cohort of HIV-infectedpatients (n = 3,413) receiving care in 4 US cities (Seattle, Birmingham, San Diego, Boston) between December 2005 and April 2010 in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS). We used generalized estimating equations to model specific substance use outcomes. RESULTS: Overall, 24% of patients reported recent use of marijuana; 9% reported amphetamine use, 9% reported crack-cocaine use, 2% reported opiate use, 3.8% reported injection drug use, and 10.3% reported polydrug use. In adjusted multivariable models, those who reported unprotected anal sex had higher odds of marijuana, amphetamine, injection drug, and polydrug use. An increased number of distinct vaginal sexual partners was associated with polydrug and crack-cocaine use. Nonadherence to antiretroviral therapy was associated with the use of all substances other than marijuana. CONCLUSIONS: The co-occurrence of substance use, unprotected intercourse, and medication nonadherence could attenuate the public health benefits of test, treat, and link to care strategies. Prevention programs are needed that address these coprevalent conditions.
Authors: K Rivet Amico; William A Fisher; Deborah H Cornman; Paul A Shuper; Caroline G Redding; Deborah J Konkle-Parker; William Barta; Jeffrey D Fisher Journal: J Acquir Immune Defic Syndr Date: 2006-08-01 Impact factor: 3.731
Authors: Nicole Crepaz; Cynthia M Lyles; Richard J Wolitski; Warren F Passin; Sima M Rama; Jeffrey H Herbst; David W Purcell; Robert M Malow; Ron Stall Journal: AIDS Date: 2006-01-09 Impact factor: 4.177
Authors: Beryl A Koblin; Marla J Husnik; Grant Colfax; Yijian Huang; Maria Madison; Kenneth Mayer; Patrick J Barresi; Thomas J Coates; Margaret A Chesney; Susan Buchbinder Journal: AIDS Date: 2006-03-21 Impact factor: 4.177
Authors: Grant Colfax; Eric Vittinghoff; Marla J Husnik; David McKirnan; Susan Buchbinder; Beryl Koblin; Connie Celum; Margaret Chesney; Yijian Huang; Kenneth Mayer; Sam Bozeman; Franklyn N Judson; Kendall J Bryant; Thomas J Coates Journal: Am J Epidemiol Date: 2004-05-15 Impact factor: 4.897
Authors: Gordon Mansergh; David W Purcell; Ron Stall; Mary McFarlane; Salaam Semaan; Jo Valentine; Ronald Valdiserri Journal: Public Health Rep Date: 2006 Mar-Apr Impact factor: 2.792
Authors: Chukwuemeka N Okafor; Zhi Zhou; Larry E Burrell; Natalie E Kelso; Nicole E Whitehead; Jeffery S Harman; Christa L Cook; Robert L Cook Journal: Am J Drug Alcohol Abuse Date: 2016-07-11 Impact factor: 3.829
Authors: Jennifer C Elliott; Lacey Critchley; Daniel J Feaster; Deborah S Hasin; Raul N Mandler; Georgina Osorio; Allan E Rodriguez; Carlos Del Rio; Lisa R Metsch Journal: Drug Alcohol Depend Date: 2019-06-05 Impact factor: 4.492
Authors: Christina S Meade; Andrea L Hobkirk; Sheri L Towe; Nan-Kuei Chen; Ryan P Bell; Scott A Huettel Journal: Drug Alcohol Depend Date: 2017-07-08 Impact factor: 4.492
Authors: Matthew J Mimiaga; Elizabeth F Closson; David W Pantalone; Steven A Safren; Jennifer A Mitty Journal: Psychol Health Med Date: 2018-09-13 Impact factor: 2.423
Authors: Amanda A Allshouse; Sam MaWhinney; Catherine M Jankowski; Wendy M Kohrt; Thomas B Campbell; Kristine M Erlandson Journal: J Acquir Immune Defic Syndr Date: 2015-06-01 Impact factor: 3.731
Authors: Kristi E Gamarel; Larry Brown; Christopher W Kahler; M Isabel Fernandez; Douglas Bruce; Sharon Nichols Journal: Drug Alcohol Depend Date: 2016-10-11 Impact factor: 4.492
Authors: Chukwuemeka N Okafor; Michael W Plankey; Michael Li; Xinguang Chen; Pamela J Surkan; Steve Shoptaw; Eileen Martin; Ronald Cohen; Ned Sacktor; Robert L Cook Journal: Subst Use Misuse Date: 2019-01-30 Impact factor: 2.164
Authors: Robin M Nance; J A Chris Delaney; Jane M Simoni; Ira B Wilson; Kenneth H Mayer; Bridget M Whitney; Frances M Aunon; Steven A Safren; Michael J Mugavero; W Christopher Mathews; Katerina A Christopoulos; Joseph J Eron; Sonia Napravnik; Richard D Moore; Benigno Rodriguez; Bryan Lau; Rob J Fredericksen; Michael S Saag; Mari M Kitahata; Heidi M Crane Journal: Ann Intern Med Date: 2018-08-21 Impact factor: 25.391